alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
### §2627. Notification regarding air release of radioactive or hazardous material

If the Secretary of Energy (or a designee of the Secretary) is notified of an improper release into the air of radioactive or hazardous material above applicable statutory or regulatory limits that resulted from waste generated by atomic energy defense activities at the Hanford Nuclear Reservation, Richland, Washington, the Secretary (or designee of the Secretary) shall—

(1) not later than two business days after being notified of the release, notify the congressional defense committees of the release; and

(2) not later than seven business days after being notified of the release, provide the congressional defense committees a briefing on the status of the release, including—

(A) the cause of the release, if known; and

(B) preliminary plans to address and remediate the release, including associated costs and timelines.

(Pub. L. 107–314, div. D, title XLIV, §4447, as added Pub. L. 115–232, div. C, title XXXI, §3115(a), Aug. 13, 2018, 132 Stat. 2291.)
#### Charles Budd Corp. v. Calnail, Inc.

Motion to dismiss appeal granted, with $10 costs, unless the appellant procures the record on appeal and appellant’s points to be served and filed on or before September 22, 1960, with notice of argument for October 4, 1960, said appeal to be argued or submitted when reached. Concur — Breitel, J. P., Rabin, Valente and Bergan, JJ.
EXHIBIT
99.4   From: Klinger, Mike
 Sent: Thursday, October 02,
2008 6:07 PM
 To: Costabile, Tom; Boldt,
Michael
 Subject: RE: Follow up Re:
4.2(d)
  I read
the document and am fine with proceeding.
  Thanks.
  Mike
Klinger
 EVP and
CFO and Treasurer
 EDCI
Holdings, Inc.
 (317)
596-0410 (o)
 (317)
809-6160 (m)
 Mike.Klinger@edcllc.com
  From: Costabile, Tom
 Sent: Thursday, October 02,
2008 5:30 PM
 To:
'michael.boldt@icemiller.com'
 Cc: Klinger, Mike
 Subject: Re: Follow up Re:
4.2(d)
  Mike,
  Thanks
again. I have no additional comments. Subject to Mike's concurrence, please
finalize.
  Thanks
& regards,
  Tommy
   From: Boldt, Michael
 To: Costabile, Tom
 Cc: Klinger, Mike
 Sent: Thu Oct 02 16:20:37
2008
 Subject: Follow up Re:
4.2(d)
  Tom,
  I
spoke to Jim. The language "on a reasonably similar basis, as determined by EDC
in it sole discretion" in 4.2(d) is optional. It can be deleted if you want to
do so.
  Mike
  ********************************************************************CIRCULAR
230 DISCLOSURE: Except to the extent that this advice concerns the qualification
of any qualified plan, to ensure compliance with U.S. Treasury Department
Regulations, we are now required to advise you that, unless otherwise expressly
indicated, any federal tax advice contained in this communication, including any
attachments, is not intended or written by us to be used, and cannot be used, by
anyone for the purpose of avoiding federal tax penalties that may be imposed by
the federal government or for promoting, marketing or recommending to another
party any tax-related matters addressed herein. CONFIDENTIALITY NOTICE:This
E-mail and any attachments are confidential and may be protected by legal
privilege. If you are not the intended recipient, be aware that any disclosure,
copying, distribution, or use of this E-mail or any attachment is prohibited. If
you have received this E-mail in error, please notify us immediately by
returning it to the sender and delete this copy from your system. Thank you.ICE
MILLER LLP
HAB HIV Core Clinical Performance Measures for 

Adult/Adolescent Clients: Group 1

Performance Measure: PCP Prophylaxis OPR-Related Measure: Yes 

www.hrsa.gov/performancereview/measures.htm

Percentage of clients with HIV infection and a CD4 T-cell count below 200 cells/mm3 who were prescribed 

PCP prophylaxis

Numerator: Number of HIV-infected clients with CD4 T-cell counts below 200 cells/mm3

 who were 

prescribed PCP prophylaxis 

Denominator: 

Number of HIV-infected clients who: 

• had a medical visit with a provider with prescribing privileges1, i.e. MD, PA, NP at 

least once in the measurement year, and 

• had a CD4 T-cell count below 200 cells/mm3 

Patient 

Exclusions: 

1. Patients with CD4 T-cell counts below 200 cells/mm3

 repeated within 3 months 

rose above 200 cells/mm3 

2. Patients newly enrolled in care during last three months of the measurement year 

Data Element: 

1. Is the client HIV-infected? (Y/N) 

a. If yes, was the CD4 T-cell count <200 cells/mm3? (Y/N) 

i. If yes, was PCP prophylaxis prescribed? (Y/N) 

1. If no, was the CD4 count repeated within 3 months? (Y/N) 

a. If yes, did it remain below 200 cells/mm3? (Y/N) 

i. If yes, was PCP prophylaxis prescribed? 

(Y/N) 

Data Sources: 

• Electronic Medical Record/Electronic Health Record 

• CAREWare, Lab Tracker, or other electronic data base 

• HIVQUAL reports on this measure for grantee under review 

• Medical record data abstraction by grantee of a sample of records 

National Goals, 

Targets, or 

Benchmarks 

for 

Comparison: 

IHI Goal: 95%2 

National HIVQUAL Data3: 

2003 2004 2005 2006 

Top 10% 100% 100% 100% 100% 

Top 25% 100% 100% 100% 100% 

Median* 93.3% 90.9% 92.3% 94.4% 

*from HAB data base

Outcome 

Measures for 

Consideration: 

° Rate of PCP in the measurement year 

° Mortality rates 

° Cost savings 

Basis for Selection and Placement in Group 1: 

Pneumocystis pneumonia (PCP) is the most common opportunistic infection in people with HIV. Without 

treatment, over 85% of people with HIV would eventually develop PCP. It is a major cause of mortality 

among persons with HIV infection, yet is almost entirely preventable and treatable. Pneumocystis almost 

always affects the lungs, causing a form of pneumonia. People with CD4 T-cell counts under 200 cells/mm3

July 2008
### §31504. Cooperative unmanned aerial vehicle activities

The Administrator, in cooperation with the Administrator of the National Oceanic and Atmospheric Administration and in coordination with other agencies that have existing civil capabilities, shall continue to utilize the capabilities of unmanned aerial vehicles as appropriate in support of Administration and interagency cooperative missions. The Administrator may enter into cooperative agreements with universities with unmanned aerial vehicle programs and related assets to conduct collaborative research and development activities, including development of appropriate applications of small unmanned aerial vehicle technologies and systems in remote areas.

(Pub. L. 111–314, §3, Dec. 18, 2010, 124 Stat. 3377.)

| Revised Section | Source (U.S. Code) | Source (Statutes at Large) |
| --- | --- | --- |
| 31504 | 42 U.S.C. 17828. | Pub. L. 110–422, title XI, §1116, Oct. 15, 2008, 122 Stat. 4813. |

Section
### §3405. Nonapplicability

(a) If, on the date of enactment of this chapter, there is in effect with respect to positions within an agency a collective-bargaining agreement which establishes the number of hours of employment a week, then this chapter shall not apply to those positions.

(b) This chapter shall not require part-time career employment in positions the rate of basic pay for which is fixed at a rate equal to or greater than the minimum rate payable under section 5376.

(Added Pub. L. 95–437, §3(a), Oct. 10, 1978, 92 Stat. 1057, §3395; renumbered §3405 and amended Pub. L. 95–454, title IX, §906(c)(1)(B), (2)(C), Oct. 13, 1978, 92 Stat. 1226, 1227; Pub. L. 101–509, title V, §529 [title I, §101(b)(9)(D)], Nov. 5, 1990, 104 Stat. 1427, 1441.)

#### **Editorial Notes**

#### References in Text

The date of enactment of this chapter, referred to in subsec. (a), is the date of the enactment of Pub. L. 95–437, which was approved Oct. 10, 1978.

#### Amendments

1990—Subsec. (b). Pub. L. 101–509 substituted "payable under section 5376" for "fixed for GS–16 of the General Schedule".

1978—Pub. L. 95–454, §906(c)(1)(B), renumbered section 3395 of this title as this section.

Subsecs. (a), (b). Pub. L. 95–454, §906(c)(2)(C), substituted "chapter" for "subchapter" wherever appearing.

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date of 1990 Amendment

Amendment by Pub. L. 101–509 effective on such date as the President shall determine, but not earlier than 90 days, and not later than 180 days, after Nov. 5, 1990, see section 529 [title III, §305] of Pub. L. 101–509, set out as a note under section 5301 of this title.

#### Effective Date of 1978 Amendment

Amendment by Pub. L. 95–454 effective 90 days after Oct. 13, 1978, see section 907 of Pub. L. 95–454, set out as a note under section 1101 of this title.
§ 550.208 If I conduct ancillary activities, what notices must I provide? At least 30 calendar days before you conduct any G&G exploration or development G&G activity (see § 550.207(a)), you must notify the Regional Supervisor in writing. ( a ) When you prepare the notice, you must: ( 1 ) Sign and date the notice;
( 2 ) Provide the names of the vessel, its operator, and the person(s) in charge; the specific type(s) of operations you will conduct; and the instrumentation/techniques and vessel navigation system you will use;
( 3 ) Provide expected start and completion dates and the location of the activity; and
( 4 ) Describe the potential adverse environmental effects of the proposed activity and any mitigation to eliminate or minimize these effects on the marine, coastal, and human environment.
( b ) The Regional Supervisor may require you to: ( 1 ) Give written notice to BOEM at least 15 calendar days before you conduct any other ancillary activity (see § 550.207(b) and (c)) in addition to those listed in § 550.207(a); and
( 2 ) Notify other users of the OCS before you conduct any ancillary activity.
### SUBCHAPTER VII—MANDATORY REMOVAL FROM EMPLOYMENT OF CONVICTED LAW ENFORCEMENT OFFICERS
**Exhibit 15**

May 11, 2006

The Board ofDirectorsCredit Suisse (USA), Inc.New York, New York

Re:  Registrationstatements No. 333-131970, 333-116241, 333-86720, 333-71850,333-62422, 333-07657, 333-34149, 333-53499, 333-73405and 333-30928

With respect to the subject registration statements,we acknowledge our awareness of the use therein of our report dated May 11,2006 related to our review of interim financial information.

Pursuant to Rule 436under the Securities Act of 1933 (the “Act”), such report is not consideredpart of a registration statement prepared or certified by an independentregistered public accounting firm, or a report prepared or certified by anindependent registered public accounting firm within the meaning ofSections 7 and 11 of the Act.
| /s/ KPMG LLP        |   |
|---------------------|--------|
| New York, New  York |

 

----
### §60122. Conditions for operation

(a) License Required for Operation.—No person that is subject to the jurisdiction or control of the United States may, directly or through any subsidiary or affiliate, operate any private remote sensing space system without a license pursuant to section 60121 of this title.

(b) Licensing Requirements.—Any license issued pursuant to this subchapter shall specify that the licensee shall comply with all of the requirements of this chapter and shall—

(1) operate the system in such manner as to preserve the national security of the United States and to observe the international obligations of the United States in accordance with section 60146 of this title;

(2) make available to the government of any country (including the United States) unenhanced data collected by the system concerning the territory under the jurisdiction of such government as soon as such data are available and on reasonable terms and conditions;

(3) make unenhanced data designated by the Secretary in the license pursuant to section 60121(e) of this title available in accordance with section 60141 of this title;

(4) upon termination of operations under the license, make disposition of any satellites in space in a manner satisfactory to the President;

(5) furnish the Secretary with complete orbit and data collection characteristics of the system, and inform the Secretary immediately of any deviation; and

(6) notify the Secretary of any significant or substantial agreement the licensee intends to enter with a foreign nation, entity, or consortium involving foreign nations or entities.

(c) Additional Licensing Requirements for Landsat 6 Contractor.—In addition to the requirements of subsection (b), any license issued pursuant to this subchapter to the Landsat 6 contractor shall specify that the Landsat 6 contractor shall—

(1) notify the Secretary of any value added activities (as defined by the Secretary by regulation) that will be conducted by the Landsat 6 contractor or by a subsidiary or affiliate; and

(2) if such activities are to be conducted, provide the Secretary with a plan for compliance with section 60141 of this title.

(Pub. L. 111–314, §3, Dec. 18, 2010, 124 Stat. 3415.)

| Revised Section | Source (U.S. Code) | Source (Statutes at Large) |
| --- | --- | --- |
| 60122 | 15 U.S.C. 5622. | Pub. L. 102–555, title II, §202, Oct. 28, 1992, 106 Stat. 4172; Pub. L. 105–303, title I, §107(f)(2), Oct. 28, 1998, 112 Stat. 2854. |

Section

In subsection (c), in the matter before paragraph (1), the words "subsection (b)" are substituted for "paragraph (b)" to correct an error in the law.
#### (A) Joseph W. Erlwein, Appellant, v. William H. Cantey et al., Defendants, and Vera Walls et al., Respondents. (B) Herman Essner, Respondent, v. Paulmoe Stationery Stores, Inc., et al., Respondents, and Stately Builders, Inc., et al., Appellants. (C) Warren Nardin et al., Doing Business as Nardin and Radoczy, Respondents, v. M. Mal Deitch, Appellant, et al., Defendants.

[In each action] Motion by appellant for leave to appeal to the Court of Appeals denied. Nolan, P. J., Beldoek, Ughetta, Kleinfeld and Pette, JJ., concur.
#### § 948.1 Scope.

This part contains all rules applicable only within West Virginia that have been adopted under the Surface Mining Control and Reclamation Act of 1977.

[46 FR 5954, Jan. 21, 1981]
### §313. Evaluation Officers

(a) Establishment.—The head of each agency shall designate a senior employee of the agency as the Evaluation Officer of the agency.

(b) Qualifications.—The Evaluation Officer of an agency shall be appointed or designated without regard to political affiliation and based on demonstrated expertise in evaluation methodology and practices and appropriate expertise to the disciplines of the agency.

(c) Coordination.—The Evaluation Officer of an agency shall, to the extent practicable, coordinate activities with agency officials necessary to carry out the functions required under subsection (d).

(d) Functions.—The Evaluation Officer of each agency shall—

(1) continually assess the coverage, quality, methods, consistency, effectiveness, independence, and balance of the portfolio of evaluations, policy research, and ongoing evaluation activities of the agency;

(2) assess agency capacity to support the development and use of evaluation;

(3) establish and implement an agency evaluation policy; and

(4) coordinate, develop, and implement the plans required under section 312.

(Added Pub. L. 115–435, title I, §101(a)(2), Jan. 14, 2019, 132 Stat. 5531.)

#### **Statutory Notes and Related Subsidiaries**

#### Effective Date

Section effective 180 days after Jan. 14, 2019, see section 403 of Pub. L. 115–435, set out as an Effective Date of 2019 Amendment note under section 306 of this title.
1 

### Farquharson, Chenise

From: Newberg, Cindy Sent: Monday, January 04, 2016 5:20 PM To: David Doniger Cc: Donaldson, David; Hillbrand, Alexander; Longstreth, Ben; Durwood Zaelke; Farquharson, Chenise; Sheppard, Margaret Subject: FW: NRDC/IGSD SNAP petition

David – my apologies! Donaldson comes up first!!

From: Newberg, Cindy Sent: Monday, January 04, 2016 3:46 PM To: Donaldson, David <Donaldson.David@epa.gov> Cc: Durwood Zaelke <zaelke@inece.org>; Hillbrand, Alexa nder <ahillbrand@nrdc.org>; 'Longstreth, Ben' <blongstreth@nrdc.org>; Farquharson, Chenise <Farqu harson.Chenise@epa.gov>; Sheppard, Margaret <Sheppard.Margaret@epa.gov> Subject: NRDC/IGSD SNAP petition

Dear David,

I would like to thank you for the useful exchange w e had on December 18, 2015 concerning the petition filed by the Natural Resources Defense Council and Institute for Governance & Sustainable Development on October 6, 2015. The petition was filed pursuant to section 612(d) of th e Clean Air Act and 40 CFR 82.184(b)(3). We found the discussion quite useful and appreciated the opportunity to cla rify a few points. We will follow up shortly with o ur formal response to your petition. In the meantime, if you have any additional questions, please give me a call at the number below.

Happy New Year!

Best, Cindy

Cindy Newberg, Chief Alternatives and Emissions Reduction Branch SPD/OAP/OAR U.S. Environmental Protection Agency +1 202-343-9729
Exhibit 18.1

September 16, 1999

Earth Sciences Inc.
910 12th Street
Golden, CO  80401

We are providing this letter to you for inclusion as an exhibit to your Form
10-QSB filing pursuant to Item 601 of Regulation S-B.

We have read management's justification for the change in accounting from
capitalizing deferred exploration costs to expensing such costs as incurred
contained in the Company's Form 10-QSB for the quarter ended March 31, 1999.
Based on our reading of the information and discussions with Company officials
about the business judgments and other factors relating to the change, we
believe management's justification to be reasonable.  Accordingly, in reliance
on management's determination and considering management's business judgment, we
concur that the newly adopted accounting principle described above is preferable
in the Company's circumstances to the method previously applied.


/s/ Hein & Associates LLP
Hein & Associates LLP
EXHIBIT 31.1

                                  CERTIFICATION

I, Dennis Vadura, certify that:

1. I have reviewed this annual report on Form 10-K/A of AccuPoll Holding Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a) designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries is made known to us by others within those entities, particularly
during the period in which this annual report is being prepared;

(b) evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

(c) disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's most recent
fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual
report) that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions);

(a) all significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

(b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.


May 20, 2005                                        /s/ Dannis Vadura
                                                     ---------------------------
                                                         Dennis Vadura
                                                         Chief Executive Officer
[Federal Register Volume 85, Number 248 (Monday, December 28, 2020)]
[Notices]
[Page 84357]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-28526]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; NTU Bench/Clinical Testing for 
COVID-19.
    Date: February 3, 2021.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, 6701 Democracy Boulevard, Room 1080, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Jing Chen, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Center for Advancing 
Translational Sciences, National Institutes of Health, 6701 
Democracy Boulevard, Room 1080, Bethesda, MD 20892-4874, 
<a href="/cdn-cgi/l/email-protection#34575c515a5e5d5a537459555d581a5a5d5c1a535b42"><span class="__cf_email__" data-cfemail="f5969d909b9f9c9b92b598949c99db9b9c9ddb929a83">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: December 18, 2020.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-28526 Filed 12-23-20; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Appeal No. 77-56.

#### Robert F. Christensen *v.*Helen S. Christensen.

*Charles J. Ajootian,*for petitioner.

*Howard I. Lvpsey,*for respondent.

The respondent’s motion that the case be remanded to Family Court for hearing on a motion for support is granted.

At the conclusion of said hearing this case will be returned to this court forthwith.
### §403–4a. Transferred

#### **Editorial Notes**

#### Codification

Section 403–4a, comprising section 104A of the National Security Act of 1947, act July 26, 1947, ch. 343, was editorially reclassified as section 3036 of this title.